Login / Signup

Cumyl-PEGACLONE: A comparatively safe new synthetic cannabinoid receptor agonist entering the NPS market?

Sebastian HalterVerena AngererJörg RöhrichOlwen GrothGabriele RoiderMaren Hermanns-ClausenVolker Auwärter
Published in: Drug testing and analysis (2018)
Keyphrases
  • health insurance
  • oxide nanoparticles